AdventHealth Infusion Center Asheville
Asheville, North Carolina, United States
Hematologist in Asheville, North Carolina
20 Medical Park Dr B, Asheville, NC 28803
About AdventHealth Infusion Center Asheville
"Formerly Asheville Hematology & Oncology - Asheville"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
32
Alliance for Clinical Trials in Oncology
12
SWOG Cancer Research Network
6
ECOG-ACRIN Cancer Research Group
4
NRG Oncology
2
Wake Forest University Health Sciences
2
Gynecologic Oncology Group
1
Clinical Trials at AdventHealth Infusion Center Asheville
During the past decade, AdventHealth Infusion Center Asheville conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 15 clinical trials were completed, i.e. on
average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
2010-02-15
2018-08-15
Completed
356
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
2011-05-25
Active, not recruiting
1,673
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AdventHealth Infusion Center Asheville" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 12 trials
sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology"
with 4 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Infusion Center Asheville"
#1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Brain Science Foundation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at AdventHealth Infusion Center Asheville
According to Clinical.Site data, the most researched conditions in "AdventHealth Infusion Center Asheville" are
"Recurrent Breast Carcinoma" (4 trials), "Colon Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Ovarian Transitional Cell Carcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "AdventHealth Infusion Center Asheville" in a lesser frequency.
Clinical Trials Intervention Types at AdventHealth Infusion Center Asheville
Most popular intervention types in "AdventHealth Infusion Center Asheville" are "Drug" (45 trials), "Other" (44 trials), "Biological" (24 trials), "Procedure" (19 trials) and "Radiation" (6 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (18 trials), "Computed Tomography" (11 trials), "Nivolumab" (10 trials) and "Biospecimen Collection" (9 trials). Other intervention names were less common.
Clinical Trials Genders at AdventHealth Infusion Center Asheville
The vast majority of trials in "AdventHealth Infusion Center Asheville" are
47 trials for "All" genders and 12 trials for "Female" genders.
Clinical Trials Status at AdventHealth Infusion Center Asheville
Currently, there are NaN active trials in "AdventHealth Infusion Center Asheville".
undefined are not yet recruiting,
15 are recruiting,
36 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in AdventHealth Infusion Center Asheville,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in AdventHealth Infusion Center Asheville, 1 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 40 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".